F30 CA247102/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2020	1
2022	1
2023	1
2025	0

Page 1

Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma.

Zhu EY, Schillo JL, Murray SD, Riordan JD, Dupuy AJ. Zhu EY, et al. iScience. 2023 Aug 31;26(10):107805. doi: 10.1016/j.isci.2023.107805. eCollection 2023 Oct 20. iScience. 2023. PMID: 37860756 Free PMC article.

Machine learning approach informs biology of cancer drug response.

Zhu EY, Dupuy AJ. Zhu EY, et al. BMC Bioinformatics. 2022 May 17;23(1):184. doi: 10.1186/s12859-022-04720-z. BMC Bioinformatics. 2022. PMID: 35581546 Free PMC article.

Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.

Vanneste M, Feddersen CR, Varzavand A, Zhu EY, Foley T, Zhao L, Holt KH, Milhem M, Piper R, Stipp CS, Dupuy AJ, Henry MD. Vanneste M, et al. Front Oncol. 2020 Apr 3;10:442. doi: 10.3389/fonc.2020.00442. eCollection 2020. Front Oncol. 2020. PMID: 32346533 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year